$
Federal Contract Award
Regeneron Pharmaceuticals INC
Department of Health and Human Services · August 6, 2025 · FY2025
HHSO100201700016CFull & OpenNAICS 541711
Obligated
$693,056,927
Contract details
- Award ID
- CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE-
- PIID
- HHSO100201700016C
- Period of performance
- September 30, 2017 → September 29, 2027
- Place of performance
- TARRYTOWN, NY, USA
- Set-aside
- None (Full & Open)
- Pricing type
- COST PLUS FIXED FEE
- PSC
- AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- NAICS
- 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Scope
IGF::OT::IGF
Parent vehicle (IDV)
Regeneron Pharmaceuticals INC
UEI N3F9MH7E6HD6
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Regeneron Pharmaceuticals INC →- UEI
- N3F9MH7E6HD6
- CAGE
- 544P9
- Parent
- Regeneron Pharmaceuticals INC
- Address
- TARRYTOWN, NY
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funding agency
- Department of Health and Human Services
- Funding office
- BARDA - ASPR / DAAPPO / BARDA DCMA
See every contract Regeneron Pharmaceuticals INC has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Regeneron Pharmaceuticals INC profile →